Infectious Diseases

FDA clears Affinity Biosensors’s LifeScale AST diagnostic platform

The US Food and Drug Administration (FDA) has granted clearance for Affinity Biosensors’s LifeScale AST system, a diagnostic tool for…

FDA authorises Prenosis’ AI-based tool for sepsis diagnosis

The US Food and Drug Administration (FDA) has granted marketing authorisation for Prenosis' AI tool Sepsis ImmunoScore, to diagnose sepsis.…

Roche wins FDA approval for first test to detect malaria in blood donors

The US Food and Drug Administration (FDA) has approved a molecular test from Roche Diagnostics that screens blood donors for…

Avoid “narrow national interest” in fighting next pandemic, WHO chief says

“Narrow national interest should not come in the way” of fighting against the next big public health threat, says World…

Roche exec says more pull incentives are needed to tackle AMR

“Pull incentives such as high cost of therapy and longer exclusivity periods, similar to those granted for orphan drugs, are…

LTS wins $1.2m grant to develop mRNA therapy patches

German pharmaceutical company Lohmann Therapie-Systeme (LTS) has received a $1.2m grant from the Bill & Melinda Gates Foundation to develop…

FDA approves first at-home chlamydia and gonorrhoea sample collection in US

The US Food and Drug Administration (FDA) has approved LetsGetChecked’s at-home testing system for chlamydia and gonorrhoea. The De Novo…

Siemens Healthineers and Global Fund target AI-enabled TB screening

Siemens Healthineers and the Global Fund to Fight AIDS, Tuberculosis and Malaria have teamed up to bring artificial intelligence (AI)-enabled…

FDA approves BodyCAP’s eCelsius Medical System

The US Food and Drug Administration (FDA) has granted approval for French MedTech company BodyCAP’s connected medical device, eCelsius Medical…

Meet the chlamydia and gonorrhoea combo test that gives results in 30 mins

A point-of-care test for chlamydia (CT) and gonorrhoea (GN) can give results in 30 minutes, the makers of the platform…

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close